MIRA DX
Mira Dx is a genomics company dedicated to the development and commercialization of novel microRNA-based diagnostic tests. The company's goal is to help clinicians better understand cancer and enhance decision making.
MIRA DX
Industry:
Biotechnology Genetics Health Care
Founded:
2008-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.miradx.com
Total Employee:
1+
Status:
Active
Contact:
2037899100
Email Addresses:
[email protected]
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Domain Not Resolving
Similar Organizations
Beta Pharma
Beta Pharma is an emerging pharmaceutical company dedicated to the discovery,and commercialization of innovative late stage therapies
Bovigen
Bovigen LLC, a genomics company, engages in the development, validation, and commercialization of genetic tools that enable producers to
Critical Diagnostics
Critical Diagnostics is engaged in the R&D and commercialization of novel biomarkers in cardiovascular diseases.
CymoGen Dx
CymoGen Dx is a genomic diagnostic company engaged in the development and application of fluorescence-based DNA detection technologies.
Med BioGene
Med BioGene Inc. is a life science company focused on the development and commercialization of genomic-based clinical lab.
MuriGen
MuriGen Therapeutics is focused on the discovery, development, and commercialization of novel drugs across a number of therapeutic areas.
Rosetta Genomics
Rosetta Genomics discovers, develops and commercializes diagnostic tests for personalized medicine.
Current Employees Featured
Founder
Investors List
Connecticut Innovations
Connecticut Innovations investment in Series A - Mira Dx
Official Site Inspections
http://www.miradx.com Semrush global rank: 2.45 M Semrush visits lastest month: 7.3 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mira Dx"
MiraDX
MiraDx is creating biomarker panels to predict both toxicity (immune-related adverse events (iRAEs)) as well as response to the developing immunotherapies. Their first test predicts …See details»
About - MiraDX
Nov 30, 2018 · MiraDx partners with universities and pharmaceutical companies to utilize our unique genetic research to help better treat cancer. MiraDx was co-founded by Joanne …See details»
Partnering - MiraDX
Nov 30, 2018 · MiraDx has several academic partnerships, allowing sample access and panel development. Some examples are the Radiogenomics program with UCLA, as well as with …See details»
MiraDX, Inc. - LinkedIn
MiraDX was founded by Joanne Weidhaas, M.D., Ph.D. and Frank Slack, Ph.D., whose cutting-edge genetic research has unveiled a new class of genetic biomarkers, based on microRNA biology. Our...See details»
Mira Dx - Crunchbase Company Profile & Funding
View contacts for Mira Dx to access new leads and connect with decision-makers. Mira Dx is a genomics company dedicated to the development and commercialization of novel microRNA-based diagnostic tests. The company's …See details»
MiraDx, Inc. Information - RocketReach
MiraDx, Inc. is a Biotechnology Research, Business Services General, and Biotechnology company_reader located in Los Angeles, California with $5.2 million in revenue and 17 …See details»
MiraDx Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for MiraDx. Use the PitchBook Platform to explore the full profile.See details»
Los Angeles-based Molecular Genetics Company MiraDx …
Apr 1, 2020 · MiraDx is a Los Angeles-based molecular genetics company that identifies, validates, develops, and delivers novel germline biomarker tests for individualized cancer …See details»
MiraDX: Unique MicroRNA-based Biomarkers – The Cancer …
MiraDx, a Los Angeles-based company, is committed to discovering meaningful ways to better treat cancer in patients with mutations like and including the KRAS-variant. They are …See details»
Press - MiraDX
MiraDx, a Los Angeles-based molecular genetics company, has transitioned its CLIA-certified lab to provide COVID-19 tests for essential workers, prioritizing hospital and field-based …See details»
MiraDx - Products, Competitors, Financials, Employees, …
MiraDx specializes in the development of microRNA-based biomarkers for the personalization of healthcare, particularly in the cancer treatment and drug development sectors. Use the CB …See details»
MiraDX Company Profile - Office Locations, Competitors, Revenue …
MiraDX is a genomics company engaged in the development and commercialization of microRNA-based diagnostic tests. Its products include PROSTOX, a radiogenomics assay for …See details»
MiraDx - Biotech Careers
Develop microRNA-based biomarkers to personalize cancer treatment and drug development. COVID-19: (09/2020) EUA Business Areas: Molecular Diagnostics, Cancer Diagnostics, …See details»
MiraDx Enrolling First-Ever Non-Tumor Based microRNA Clinical …
Jan 9, 2020 · Molecular genetics company MiraDx announced it is opening patient enrollment in collaboration with UCLA for a first-ever non-tumor based microRNA biomarker-driven clinical …See details»
Contact - MiraDX
MiraDX. We use our unique microRNA-based biomarkers to personalize cancer treatments and drug development.See details»
Miradx Careers and Employment | Indeed.com
Jan 22, 2024 · Find out what works well at Miradx from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles …See details»
MiraDx SARS-CoV-2 RT-PCR assay - Patient Fact Sheet
What is the MiraDx SARS-CoV-2 RT-PCR Assay? The test is designed to detect the virus that causes COVID-19 in certain upper respiratory specimens such as nasal, mid-turbinate, …See details»
Pipeline - MiraDX
MiraDX is committed to discovering meaningful ways to better treat cancer in patients with variants like and including the KRAS-variant. We are developing answers by applying our …See details»
Molecular Genetics Company MiraDx Offers COVID-19 Viral
May 28, 2020 · MiraDx is a Los Angeles-based molecular genetics company that identifies, validates, develops, and delivers novel germline biomarker tests for individualized cancer …See details»
Latest updates - miradx.com
Sep 30, 2021 · MiraDx, in collaboration with the UCLA Jonsson Comprehensive Cancer Center, is conducting a clinical trial to validate a novel prostate cancer biomarker panel designed to help …See details»